Big Pharma

Head of Business Development, Search & Evaluation or External Innovation for Neuroscience.

This forum offers the opportunity for:

  • Evaluation and comparison of related assets, pipelines and platforms
  • Understanding of relevant scientific context to validate innovations and support strategic decision-making
  • A boutique touchpoint for follow-up outside of JPM and BIO, with more time to give detailed guidance and feedback

I liked the format it meant the companies knew what Sanofi was looking for and made the 30-minute meetings very efficient.” Sanofi, Neuroscience Innovation Partnering & Licensing Summit 2025

Biotech

Founders, C-Suite, Heads of Business Development Ensuring relevant exposure, biotech join this different format to:

  • Network more efficiently with less competition to engage with key stakeholders
  • Understand positioning and pitches of competitors to sharpen own differentiation
  • Gain multiple 1-2-1 meetings for feedback on data packages to action ahead of BIO or other conferences later in the year

The event assembled a diverse set of stakeholders extremely relevant for partnering in this specific field. It was the right size, meaning organic opportunities for connectionsCEO, Neuroscience Innovation Partnering & Licensing Summit 2025

Investors

Corporate Venture & Venture Capital Connecting investors to both pharma and biotech teams, this unique opportunity allows investors to:

  • Understand pharma’s reception to innovation developed by leading biotech to inform portfolio direction and exit strategies
  • Efficiently gain landscape updates and information from private biotech

The high seniority and high quality of participants made it easier than usual to get a meeting with the right people, primarily pharma.Investor, Neuroscience Innovation Partnering & Licesning Summit 2025

Explore the Full Event Guide

  • 5 to 1 ratio of biotech to pharma and investors
  • 30%+ acceptance rate on meeting platform
  • Pharma and investors present in >50% of meetings
  • Two formal structured networking sessions, one informal drinks reception
  • Refine your strategy, strengthen your pitch, nurture your relationships to stay front-of-mind after JPM and before BIO
2nd Neuroscience Innovation Partnering & Licensing Brochure Image

Attending Companies Include

Explore Agenda - 2nd Neuroscience Innovation Partnering & Licensing
Review the Program

Confidently evaluate if this targeted networking opportunity aligns with your partnering objectives. Review the format, speaker faculty and remaining presentation sessions in the full event guide.

Partner with us - 2nd Neuroscience Innovation Partnering & Licensing
Register to Join

Bridging the gap between innovative R&D and partnership conversations; deliberately timed between JPM and BIO. Register with earlybird discounts, secure a presentation opportunity whilst they remain, and share your company logo with us to advertise as attending on this website.

Why Partner - 2nd Neuroscience Innovation Partnering & Licensing
Become a Founding Partner

If you’re a law firm, or bank, or offer -omics, CRO or CDMO services and you’re looking for a differentiated and near exclusive opportunity to associate your brand awareness with high-value interactions, review information about becoming a founding partner here.